Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01458938
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:18.231953+00:00
Published At
2017-02-01T00:00:00+00:00
Record Updated At
2017-02-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Spinal Disease", "Spinal Radiculopathy", "Myelopathy", "Neurogenic Claudication"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-02-01"
protocolSection.identificationModule.nctId
"NCT01458938"
protocolSection.identificationModule.officialTitle
"Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Spinal Disease (protocolSection.conditionsModule.conditions)
  • Spinal Radiculopathy (protocolSection.conditionsModule.conditions)
  • Myelopathy (protocolSection.conditionsModule.conditions)
  • Neurogenic Claudication (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.